Thursday, May 21, 2020 10:18:40 AM
BOING set to pop higher. No one knows if 2nd-wave (covid-19) FEARS will materialize in ANY meaningful way; however, I expect BA to recover just under 50% of pre-Covid highs by the end of the year & demonstrably so from September (into Holidays as we move into the New Year).
As mentioned to YOU before: I don't make ANY specific calls to others because YOU NEVER know what their level of EXPERIENCE investing is. But MORE IMPORTANTLY, their REASONS for investing, goals, timelines, etc.. & sometimes that's MORE IMPORTANT than what they're investing in &/or ought to INFORM what, how, when, etc..
I chart, study fundamentals, macro developments & have a VERY HEALTHY & ROBUST RISK tolerance so I take MORE chances than many. And those choices tend towards being VERY CALCULATED. Not always, but that's the goal. And what's right for me, may not be for a retiree, new investor, etc.. They may NOT even have tools & skills to write calls or puts for example & make money (or reduce losses) if an investment goes sideways, the market turns against them, COVID-2 happens or whatever... So MY POSTS, decisions & DECLARATIONS are more to keep MYSELF honest. Hey, I bought this @ this time, see this, etc.. & act accordingly. MOSTLY in real time. You don't see alot of that on these boards... But I think its the ONLY way to evaluate my trading. GL
Recent LH News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 12:08:36 PM
- Labcorp to Webcast Its Annual Meeting of Shareholders • PR Newswire (US) • 05/08/2024 10:59:00 AM
- Invitae Receives Court Approval for Sale to Labcorp • PR Newswire (US) • 05/07/2024 08:05:00 PM
- Form PX14A6G - Notice of exempt solicitation submitted by non-management • Edgar (US Regulatory) • 05/06/2024 08:40:23 PM
- Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B • PR Newswire (US) • 04/29/2024 11:00:00 AM
- Labcorp Announces 2024 First Quarter Results • PR Newswire (US) • 04/25/2024 10:58:00 AM
- Labcorp Announces Winning Bid for Select Assets of Invitae • PR Newswire (US) • 04/25/2024 01:27:00 AM
- Invitae Enters into Agreement with Labcorp for Sale of Business • PR Newswire (US) • 04/25/2024 01:19:00 AM
- Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw • PR Newswire (US) • 04/15/2024 11:00:00 AM
- Labcorp Declares Quarterly Dividend • PR Newswire (US) • 04/11/2024 10:59:00 AM
- Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit • PR Newswire (US) • 04/10/2024 10:49:00 AM
- Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs • PR Newswire (US) • 04/08/2024 11:00:00 AM
- Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research • PR Newswire (US) • 04/05/2024 11:00:00 AM
- Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research • PR Newswire (US) • 04/02/2024 11:00:00 AM
- Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp • Business Wire • 04/01/2024 12:00:00 PM
- The Prelude Network® Names Labcorp Its Preferred Genetic Carrier Screening Lab • PR Newswire (US) • 03/29/2024 01:00:00 PM
- Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business • PR Newswire (US) • 03/28/2024 12:00:00 PM
- Labcorp to Announce First Quarter Financial Results on April 25, 2024 • PR Newswire (US) • 03/27/2024 11:00:00 AM
- Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials • PR Newswire (US) • 03/20/2024 11:00:00 AM
- Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer • PR Newswire (US) • 03/16/2024 02:29:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 12:59:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 12:56:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 06:16:55 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 03:34:20 PM
- Labcorp Launches Weight Loss Management Testing Solutions • PR Newswire (US) • 03/07/2024 12:00:00 PM
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM